We & Win Diversification Co., Ltd. (4113.TWO)
- Previous Close
22.75 - Open
22.10 - Bid 21.30 x --
- Ask 21.35 x --
- Day's Range
21.10 - 22.10 - 52 Week Range
18.60 - 68.50 - Volume
1,250,267 - Avg. Volume
632,048 - Market Cap (intraday)
4.923B - Beta (5Y Monthly) 0.01
- PE Ratio (TTM)
6.03 - EPS (TTM)
3.53 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 17, 2022
- 1y Target Est
--
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.
kh.vvvvv.com.tw36
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4113.TWO
View MorePerformance Overview: 4113.TWO
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4113.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4113.TWO
View MoreValuation Measures
Market Cap
5.26B
Enterprise Value
11.01B
Trailing P/E
6.44
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.87
Price/Book (mrq)
1.16
Enterprise Value/Revenue
1.93
Enterprise Value/EBITDA
10.37
Financial Highlights
Profitability and Income Statement
Profit Margin
13.49%
Return on Assets (ttm)
4.57%
Return on Equity (ttm)
20.18%
Revenue (ttm)
5.72B
Net Income Avi to Common (ttm)
770.81M
Diluted EPS (ttm)
3.53
Balance Sheet and Cash Flow
Total Cash (mrq)
1.06B
Total Debt/Equity (mrq)
154.06%
Levered Free Cash Flow (ttm)
2.16B